beta
/Regulatory news: Avalglucosidase alfa‐ngpt (Nexviazyme) for late‐onset Pompe disease—FDA approval summary
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)